Comparison of clinical efficacy and safety of stent-assisted coil embolization for intracranial aneurysms

doi:10.19854/j.cnki.1008-2425.2024.03.0005

Abstract

Abstract: Objective Exploring the clinical efficacy and safety analysis of stent assisted coil embolization in the treatment of intracranial aneurysms,aiming to provide reference for related clinical research.Methods Seventy-two patients with intracranial aneurysms admitted to our hospital from December 2020 to October 2022 were selected as the study subjects.They were divided into two groups according to the condition and surgical treatment plan.The control group was treated with simple spring embolism; The study group used stent-assisted coil embolization.The clinical efficacy and safety of the two groups were observed.Results ①In the control group,11 cases were completely cured and 8 cases were basically cured,with a total effective rate of 63.33%; In the observation group,22 cases were completely cured and 18 cases were basically cured.The total effective rate was 95.24%.The therapeutic effect of the observation group was significantly higher than that of the control group,and there was a significant difference in the total effective rate between the two groups(P<0.05).②In the control group,8 cases of adverse events occurred during the treatment,with a total incidence of 26.67%; There were 2 cases of adverse events during the treatment in the observation group,with a total incidence of 4.76%.The number of adverse events in the observation group was significantly lower than that in the control group,and there was a statistically significant difference in the total incidence of adverse events between the two groups(P<0.05).Conclusion Stent-assisted coil embolization is effective and safe for patients with intracranial aneurysms,which is worthy of further clinical promotion and application.

Key words: Intracranial aneurysm, Stent-assisted coil embolization, Simple coil embolism, Clinical efficacy, Security

摘要： 目的探讨支架辅助弹簧圈栓塞治疗颅内动脉瘤临床治疗疗效与安全性分析,旨在为相关临床研究提供参考。方法选取我院2020年12月~2022年10月收治的72例颅内动脉瘤患者作为研究对象,根据病情及手术方式不同分为2组。对照组采用单纯弹簧栓术;观察组采用支架辅助弹簧圈栓塞术。观察2组患者的临床治疗疗效和安全性。结果 ①对照组完全治愈11例、基本治愈8例,总有效率63.33%;观察组完全治愈22例、基本治愈18例,总有效率95.24%。观察组治疗疗效明显高于对照组,对比2组患者治疗的总有效率存在明显差异具有统计学意义(P<0.05)。②对照组治疗期间发生不良事件8例、总发生率26.67%;观察组治疗期间发生不良事件2例、总发生率4.76%。观察组发生不良事件数显著低于对照组,对比2组患者的不良事件总发生率存在差异具有统计学意义(P<0.05)。结论对于颅内动脉瘤患者采用支架辅助弹簧圈栓塞治疗具有确切的疗效且安全性较高,值得临床进一步推广及应用。

关键词: 颅内动脉瘤, 支架辅助弹簧圈栓塞, 单纯弹簧圈栓塞, 临床疗效, 安全性

CLC Number:

R739.4

Hua Xiangting, Fan Kui, Li Yufeng, Cui Tao, Zhang Chaoyong. Comparison of clinical efficacy and safety of stent-assisted coil embolization for intracranial aneurysms[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(3): 152-155.

滑祥廷, 范奎, 李玉峰, 崔涛, 张超勇. 支架辅助弹簧圈栓塞治疗颅内动脉瘤临床治疗疗效与安全性分析[J]. 立体定向和功能性神经外科杂志, 2024, 37(3): 152-155.

References

[1] 杨明贵,任成龙,王东,等.颅内动脉瘤破裂风险CT血管成像分析[J].实用放射学杂志,2020,36(3):381~384,405.
[2] 中国医师协会神经介入专业委员会,中国颅内动脉瘤计划研究组[J].中国颅内未破裂动脉瘤诊疗指南2021[J].中国脑血管病杂志,2021,18(9):634~664.
[3] 李新.颅内动脉瘤破裂致急性蛛网膜下腔出血患者行脑组织CT灌注成像的意义[J].中国药物与临床,2021,21(20):3393~3395.
[4] Bechan RS,Sprengers ME,Majoie CB,et al.Stent-assisted coilembolization of intracranial aneurysms:complications in acutely ruptured versus unruptured aneurysms[J].AJNR Am J Neuroradiol,2016,37(3):502~507.
[5] Wang J,Vargas J,Spiotta A,et al.Stent-assisted coiling of cerebral aneurysms:a single-center clinical and angiographic analysis[J].J Neurointerv Surg,2018,10(7):687~692.
[6] 程魁红,赵刚,张锡武,等.颅内动脉瘤的支架辅助弹簧圈栓塞的疗效分析[J].中国临床神经外科杂志,2022,27(8):633~636.
[7] 廖羽,范英俊,王玉珏.Lvis支架辅助弹簧圈栓塞治疗未破裂宽颈颅内动脉瘤及对神经功能、血流动力学的影响[J].实用医院临床杂志,2022,19(1):118~121.
[8] Chalouhi N,Hoh BL,Hasan D.Review of cerebral aneurysm formation,growth,and rupture[L].Stroke,2013,44(12):3613~3622.
[9] Shi Y,Li SC,Song YY,et al.Nrf-2 signaling inhibits intracranial aneurysm formation and progression by modulating vascular smooth muscle cell phenotype and function[J].J Neuroinflammation,2019,16(1):185.
[10] Wang Y,Wang C,Yang Q,et al.ANXA3 silencing ameliorates intracranial aneurysm via inhibition of the JNK signaling pathway[J].Mol Ther Nucleic Acids,2019,17:540~550.
[11] Powell AE,Fernandez BA,Maroun F,et al.Familial intracranial aneurysm in Newfoundland:clinical and genetic analysis[J].Can J Neurol Sci,2019,46(5):518~526.
[12] Raymond J,Guilbert F,Weill A,et al.Long-term angiographicrecurrences after selective endovascular treatment of aneurysms with detachable coils[J].Stroke,2003,34(6):1398~1403.
[13] Inoue A,Tagawa M,Matsumoto S,et al.Utility of bulging technique for endovascular treatment of small and wide-neckedaneurysms with a Low-profile Visualized Intraluminal Support(LVISJr.) device:A case report and review of the literature[J].Interv Neuroradiol,2018,24(2):125~129.
[14] 蒋宽,许文辉,周志平,等.支架辅助栓塞与单纯栓塞治疗颅内动脉瘤的安全性和有效性对比分析[J].中国现代手术学杂志,2022,26(3):205~210.
[15] Fiorella D,Boulos A,Turk AS,et al.The safety and effectiveness of the LVIS stent system for the treatment of wide-necked cerebral aneurysms:final results of the pivotal US LVIS trial[J].J Neurointerv Surg,2019,11(4):357~361.
[16] Hackenberg KAM,Hänggi D,Etminan N.Unruptured intracranial aneurysms[J].Stroke,2018,49(9):2268~2275.